The report offers detailed coverage of Irritable Bowel Syndrome (IBS) industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Irritable Bowel Syndrome (IBS) by geography. The report splits the market size, by volume and value, on the basis of application type and geography.
Irritable bowel syndrome (IBS) is defined as recurrent abdominal pain or discomfort that occurs in association with altered bowel habits over a period of at least 3 months. The disorder is classified into three main subtypes, according to the predominant bowel habits presented: constipation-predominant IBS (IBS-C), diarrhea-predominant IBS (IBS-D), and mixed-presentation IBS (IBS-M). IBS is among the most common gastrointestinal disorders, with an estimated pooled international IBS prevalence rate of about 11.2%.
The report forecast global Irritable Bowel Syndrome (IBS) market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2020-2028.
First, this report covers the present status and the future prospects of the global Irritable Bowel Syndrome (IBS) market for 2015-2028.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].
Key Companies
Allergan
Valeant Pharmaceuticals
Takeda
Sucampo Pharmaceuticals
McNeil Consumer Healthcare
Sebela Pharmaceuticals
Astellas Pharmaceuticals
IM HealthScience
At the same time, we classify Irritable Bowel Syndrome (IBS) according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.
Market by Order Type
IBS-D Drug
IBS-C Drug
Other
Market by Application
Women
Men
Market Segment as follows:
By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]
The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Irritable Bowel Syndrome (IBS) market for the forecast period 2020 - 2028?
• What are the driving forces in the Irritable Bowel Syndrome (IBS) market for the forecast period 2020 - 2028?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Irritable Bowel Syndrome (IBS) industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?